Information  X 
Enter a valid email address

Benchmark Hlgs PLC (BMK)

  Print   

Thursday 25 May, 2017

Benchmark Hlgs PLC

Trading Update and Notice of Results

RNS Number : 1690G
Benchmark Holdings PLC
25 May 2017
 

 

Benchmark Holdings PLC

25 May 2017

 

Benchmark Holdings plc
("Benchmark", the "Company" or the "Group")

Trading Update and Notice of Results

Benchmark, the aquaculture biotechnology and food chain sustainability business, announces that Group performance for the six months to 31 March 2017 was broadly in line with the Board's expectations.

Highlights of the first half year include:

·      Benchmark signed a joint venture agreement with SalMar ASA, through which it will provide genetics, health and knowledge services to the world's third largest salmon producer.  This is an important acknowledgement of Benchmark's technology, and exemplifies its strategy to provide a suite of technology solutions to the aquaculture industry.

·      Construction of the Group's new salmon egg production facility in Norway continued on schedule.  This important development will underpin Benchmark Breeding and Genetics' market leading position in the sector.

·      Good progress was made in Advanced Animal Nutrition towards the goal of delivering 100% live replacement for feeding juvenile shrimp, a key to unlocking future growth potential for the industry.

·      As anticipated, the Animal Health division saw significantly lower demand for Salmosan in Norway due to an industry focus on new solutions to the significant sea lice challenge.

·      Good progress was made towards the commercial field trials launch of a ground-breaking sea lice treatment.  Significant revenues from this product are anticipated in H2 and beyond, which are projected to support achievement of the Board's expectations for FY 2017 following the challenging first half for Salmosan.

·     The new state-of-the-art vaccine manufacturing facility in Braintree is being commissioned and first commercial batches are expected in H2.

 

In the shrimp sector, disease challenge coupled with low market prices resulted in delayed sector investment and lower growth rates in the first half year.  The Group has proceeded cautiously with new investments, whilst continuing to progress core infrastructure projects which support long term growth.

The Group is seeking to grow sales and market share in developing markets, including China, for its Breeding and Genetics and Advanced Animal Nutrition Divisions, and is progressing towards establishing strategic relationships in those regions. Further progress has been made with the development of the Group-wide customer account management programme, which will promote the full benefit of Benchmark's integrated technology solutions in aquaculture.

The long term drivers of growth in the Company's sectors, which include the growing global demand for aquaculture products and an ever increasing pressure to limit the use of antibiotics in the food chain, remain strong, with increasing momentum and interest in the aquaculture market. The Company continues to focus on delivery of its strategy to deploy leading technologies drawn from across the Group, through established distribution channels, into long-term growth markets.

Benchmark expects to announce its interim results for the six months to 31 March 2017 during the week commencing 26 June 2017.

 

Commenting on trading, Benchmark's Chief Executive Officer, Malcolm Pye, said: 

"The agreement with SalMar is an example of the value we can deliver to our customers by aggregating leading technologies to provide integrated solutions to the issues faced by the food production industry. There are a number of technologies in the later stages of development that we are particularly excited about, and we look forward to delivering these, through our distribution networks, including into the significant Asian and Latin American shrimp and tilapia markets."

 

-Ends-

 

 

For further information, please contact:

 

Benchmark Holdings plc

 Tel: 020 7920 3150

 Malcolm Pye, CEO

 Roland Bonney, COO

 Rachel Aninakwah, Communications

 

Numis

 Tel: 020 7260 1000

 Michael Meade / Freddie Barnfield (NOMAD)

 James Black (Corporate Broking)

 

Tavistock

 Tel: 020 7920 3150

 Niall Walsh / Simon Hudson

 

 

Notes to Editors:

 

Benchmark challenges the status quo in aquaculture, agriculture and animal healthcare.

Since 2000, Benchmark has consistently worked to build a platform to serve its customers, helping farmers to take control of their biological environment through the combination of genetics, nutrition, health and knowledge services. Through its in-depth knowledge of animal biology Benchmark is able to tackle the key issues in the aquaculture, livestock and companion animal sectors.

The Company has proven distribution capabilities in high growth markets and operates internationally with R&D facilities, commercial farms, diagnostic laboratories, manufacturing sites, production facilities and commercial offices across 27 countries in five continents. As at 28 February 2017, Benchmark employed 900 people.

For further information on Benchmark please visit www.benchmarkplc.com


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTLLFVDEVISFID

a d v e r t i s e m e n t